Patents Assigned to ENGEN MEDICAL CORPORATION
  • Use of american ginseng to counteract cannabis-induced intoxication
    Patent number: 10660864
    Abstract: A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide. A composition and method for the use of falcarinol for the attenuation of Cannabis-induced dysphoria and reverse cannabis tolerance where the dosage of at least 30 mg can be effectively administered for buccal absorption.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: May 26, 2020
    Assignee: ENGEN MEDICAL CORPORATION
    Inventors: Paul Epner, Richard Zimmer, III, Bill W. Massey
  • Use of american ginseng to counteract cannabis-induced intoxication
    Patent number: 10350253
    Abstract: A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: July 16, 2019
    Assignee: ENGEN MEDICAL CORPORATION
    Inventors: Paul Epner, Richard Zimmer, III, Bill W. Massey